Invesco Pharmaceuticals ETF
PJP
86 hedge funds and large institutions have $89.7M invested in Invesco Pharmaceuticals ETF in 2020 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 24 increasing their positions, 16 reducing their positions, and 9 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 16
19% more capital invested
Capital invested by funds: $75.5M → $89.7M (+$14.2M)
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
0% more funds holding
Funds holding: 86 → 86 (0)
0.16% less ownership
Funds ownership: 25.37% → 25.21% (-0.16%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$2.32M |
| 2 |
AWMS
Advocacy Wealth Management Services
Atlanta,
Georgia
|
+$2.11M |
| 3 |
LPL Financial
San Diego,
California
|
+$1.16M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$775K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$724K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCI
Brinker Capital Investments
Berwyn,
Pennsylvania
|
-$2.66M |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$2.51M |
| 3 |
Envestnet Asset Management
Chicago,
Illinois
|
-$2.04M |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$1.42M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.11M |
PJP Hedge Fund Activity: Q2 2020 in Review
86 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q2 2020, worth a combined $89.7M — up 19% from $75.5M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new PJP positions and 9 closed out — a net gain of 1 holder — while 24 added to existing stakes and 16 trimmed.
The largest buyer was Royal Bank of Canada, adding an estimated $2.32M. The largest seller was Brinker Capital Investments, cutting an estimated $2.66M.
- 86 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q2 2020, unchanged from Q1 2020.
- Funds reported $89.7M of Invesco Pharmaceuticals ETF stock for Q2 2020, up 19% quarter-over-quarter.
- 10 funds opened new Invesco Pharmaceuticals ETF positions in Q2 2020 and 9 closed out, a net change of +1 holder.
- The largest Invesco Pharmaceuticals ETF buyer in Q2 2020 was Royal Bank of Canada, an estimated $2.32M added.
- The largest Invesco Pharmaceuticals ETF seller in Q2 2020 was Brinker Capital Investments, an estimated $2.66M sold.
Based on aggregated 13F filings for Q2 2020.